Dr. David S. Gibson is a Senior Lecturer at the School of Biomedical Sciences, Ulster University. After his Biochemistry degree, he worked at Randox Laboratories Ltd and was responsible for designing and commercializing novel biochip array diagnostic tests. He was awarded a PhD in 2001 from the Centre for Cancer Research and Cell Biology, Queen’s University Belfast (QUB). In 2009, he was awarded a prestigious travel fellowship from Arthritis Research UK to conduct mass spectrometry-based research at the Duncan laboratory at the University of Colorado, Denver over two years. He is particularly interested in developing new prognostic and predictive tools to improve the clinical management of arthritis patients.